is liraglutide better than tirzepatide vs semaglutide and for weight loss in patients with overweight or obesity without diabetes: A short-term cost-effectiveness analysis in the United States Liraglutide vs. Tirzepatide For Weight

Active Ingredient : Semaglutide, a GLP-1 receptor agonist Mechanism of Action : According to FDA prescribing information, semaglutide works by: Increasing glucose-dependent insulin secretion Decreasing glucagon secretion Slowing gastric emptying Acting on centers in the brain that regulate appetite Clinical Trial Evidence - STEP Program : According to published data from the STEP 1 trial (New England Journal of Medicine, 2021): Study Design : 68-week randomized, double-blind, placebo-controlled trial 1,961 adults without diabetes Inclusion: BMI 30 or 27 with weight-related conditions Intervention: Once-weekly subcutaneous semaglutide 2.4 mg Lifestyle: 500-calorie deficit diet plus 150 minutes/week physical activity Primary Results : Semaglutide group: Average 14.9% body weight loss (approximately 33 lbs for 220 lb individual) Placebo group: Average 2.4% body weight loss (approximately 5 lbs for 220 lb individual) Difference: 12.4 percentage points (p 3 pounds/week associated with higher risk

Cons of Contrave : Possible side effects, including nausea, headache, and increased blood pressure.Most individuals do not respond as effectively to Contrave as to other weight loss medications

As with any medication, it is crucial to discuss potential side effects with a trained healthcare provider like such as Dr

Reta (Research Grade)